ORMP
Oramed Pharmaceuticals Inc
4.50$
+0.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2003 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | -843.9% | -1,249.1% | – | – | – | 726.2% | -237.4% | -598.5% | -478.7% | -459.0% | -783.6% | -1,061.8% | -768.3% | – | -457.3% | |
| – | – | – | – | – | – | – | 14.3% | 8.0% | – | – | – | 0.6% | 0.2% | 0.2% | 0.3% | 0.3% | 2.8% | 2.1% | 14.6% | – | 6.1% | |
| – | – | – | – | – | – | – | 268.1% | 147.2% | – | – | – | 98.9% | 64.1% | 63.2% | 29.9% | 17.2% | 99.7% | 425.8% | 314.3% | – | 299.6% | |
| – | – | – | – | – | – | – | -28.5% | 140.9% | – | – | – | 2,346.8% | 117.0% | -147.2% | 10.7% | -116.5% | -48.6% | -34.9% | -201.2% | – | -95.4% | |
| – | – | – | – | – | – | – | 1.1% | 1.2% | – | – | – | 1.4% | 0.3% | 0.2% | 0.6% | 3.0% | 13.9% | 18.3% | 19.0% | – | 96.7% | |
| – | – | – | – | – | – | – | -868.5% | 960.0% | – | – | – | -2,497.7% | 175.2% | -286.0% | 416.5% | 170.7% | -823.7% | 1,117.7% | -5,450.6% | – | 272.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 543.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | – | -237.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 3,697.8% | – | 0.0% | |
| – | – | – | – | – | – | – | 1,871.3% | 1,893.6% | – | – | – | 1,878.8% | 64.6% | 925.0% | – | 877.7% | 3,751.1% | 427.7% | 3,879.0% | – | -237.0% | |
| – | – | – | – | – | – | – | 158.9% | 1,583.3% | – | – | – | 108.3% | 2.5% | 41.3% | -61.7% | 589.2% | 2,143.9% | -1,360.7% | -2,344.0% | – | -423.7% | |
| – | – | – | – | – | – | – | -845.0% | -1,250.3% | – | – | – | 724.8% | -237.7% | -598.7% | -479.3% | -462.1% | -797.5% | -1,080.2% | -787.2% | – | -553.9% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.